News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,847 Results
Type
Article (13831)
Company Profile (293)
Press Release (244723)
Section
Business (79302)
Career Advice (148)
Deals (13176)
Drug Delivery (31)
Drug Development (50261)
Employer Resources (31)
FDA (5669)
Job Trends (5109)
News (144021)
Policy (10014)
Tag
Academia (901)
Alliances (21438)
Alzheimer's disease (729)
Approvals (5632)
Artificial intelligence (58)
Bankruptcy (97)
Best Places to Work (4455)
Biotechnology (241)
Breast cancer (54)
Cancer (564)
Cardiovascular disease (51)
Career advice (129)
CAR-T (43)
Cell therapy (146)
Clinical research (39568)
Collaboration (199)
Compensation (83)
COVID-19 (998)
C-suite (49)
Cystic fibrosis (61)
Data (600)
Diabetes (62)
Diagnostics (1190)
Earnings (28560)
Events (46446)
Executive appointments (149)
FDA (5909)
Funding (205)
Gene editing (47)
Gene therapy (125)
GLP-1 (288)
Government (1063)
Healthcare (6525)
Infectious disease (1027)
Inflammatory bowel disease (89)
IPO (7166)
Job creations (860)
Job search strategy (125)
Layoffs (181)
Legal (1372)
Lung cancer (100)
Manufacturing (64)
Medical device (2547)
Medtech (2548)
Mergers & acquisitions (6084)
Metabolic disorders (198)
Neuroscience (907)
NextGen Class of 2024 (1994)
Non-profit (841)
Northern California (772)
Obesity (115)
Opinion (90)
Parkinson's disease (55)
Patents (45)
People (24879)
Pharmaceutical (48)
Phase I (13905)
Phase II (18395)
Phase III (11679)
Pipeline (135)
Postmarket research (846)
Preclinical (5866)
Radiopharmaceuticals (203)
Rare diseases (138)
Real estate (1409)
Regulatory (8155)
Research institute (930)
Southern California (712)
Startups (1963)
United States (6484)
Vaccines (152)
Weight loss (70)
Date
Today (91)
Last 7 days (469)
Last 30 days (1694)
Last 365 days (20683)
2024 (17553)
2023 (22413)
2022 (26823)
2021 (27809)
2020 (23358)
2019 (16225)
2018 (11738)
2017 (13747)
2016 (11842)
2015 (14354)
2014 (10395)
2013 (7484)
2012 (7532)
2011 (7615)
2010 (7429)
Location
Africa (146)
Asia (16759)
Australia (2818)
California (1749)
Canada (637)
China (133)
Colorado (64)
Connecticut (69)
Europe (36060)
Florida (189)
Georgia (50)
Illinois (109)
Indiana (51)
Kansas (54)
Maryland (256)
Massachusetts (1442)
Michigan (45)
Minnesota (81)
New Jersey (478)
New York (532)
North Carolina (378)
Northern California (772)
Ohio (71)
Pennsylvania (370)
South America (207)
Southern California (712)
Texas (177)
Washington State (196)
258,847 Results for "avila therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Business
Atea Pharmaceuticals Appoints Claudio Avila, MB, BS, Ph.D., as Senior Vice President of Medical Affairs
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and development of oral therapeutics for severe viral infections, announced the appointment of Claudio Avila, MB, BS, Ph.D., as Senior Vice President of Medical Affairs.
June 15, 2021
·
4 min read
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Genetown
Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular Protein Degrader Platform at the American Association of Immunologists Annual Meeting
Avilar Therapeutics today announced it will present preclinical proof-of-concept data for the company’s MTAC (M6PR Targeting Chimera) protein degrader platform at IMMUNOLOGY™ 2024, the American Association of Immunologists annual meeting.
May 1, 2024
·
3 min read
Layoffs
Relay Therapeutics to Lay Off 10% of Workforce
Relay Therapeutics is cutting its workforce to help streamline its research organization as it looks to complete its first large-scale, pivotal clinical trial.
October 4, 2024
·
1 min read
·
Angela Gabriel
Layoffs
Sage Therapeutics Will Lay Off 33% of Employees, Including Over Half of R&D
As part of a strategic reorganization intended in part to support the ongoing launch of its postpartum depression drug, Sage Therapeutics is cutting more than 165 employees.
October 17, 2024
·
2 min read
·
Angela Gabriel
Press Releases
Allogene Therapeutics Announces Participation in November Investor Conferences
November 4, 2024
·
2 min read
Pharm Country
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Aquestive Therapeutics, Inc. announced that the Aquestive management team will participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism and host investor meetings on July 9, 2024.
June 27, 2024
·
2 min read
Press Releases
Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company
September 30, 2024
·
8 min read
1 of 25,885
Next
